How many institutions held ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value in Q2 2022?

112 institutional investors reported ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value for Q2 2022. Use the holders table for investor-level position and value details.

Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)

Q: What does CUSIP 00461U105 represent in this 13F holders report?

CUSIP 00461U105 is the security identifier for ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value used to aggregate holder disclosures.

CUSIP: 00461U105

Q2 2022 13F Holders as of 30 Jun 2022

Security type / class: Equity / Common Stock, $0.00001 par value
Shares outstanding: 138,752,791
Total 13F shares: 63,269,555
Share change: +4,048,205
Total reported value: $883,318,693
Put/Call ratio: 110%
Reported price per share: $13.96
Number of holders: 112
Value change: +$55,162,166
Number of buys: 58
Number of sells: 34

Security key

00461U105

Report period

Q2 2022

Institutions

112

Top holders

ACRS full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2022 Previous quarter: Q1 2022 Aclaris Therapeutics, Inc. SEC filings Aclaris Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 00461U105

Newer quarter: Q3 2022 Previous quarter: Q1 2022

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

WELLINGTON MANAGEMENT GRO...

13D/G signal

—

Evidence rows

Latest as of

31 Mar 2022

13F Lead comparable stake: 4.1% Showing 1-6 of 15 holder rows.

Rank 1 holder

WELLINGTON MANAGEMENT GROUP LLP

13F

Ownership: 4.1%
Position: $98.79M

13F

Rank 2 holder

Venrock Adviser, LLC

13F

Ownership: 3.3%
Position: $78.68M

13F

Rank 3 holder

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
WELLINGTON MANAGEMENT GROUP LLP	13F Company 13F	4.1%	$98,789,000 5,730,253 shares	—	31 Mar 2022
Venrock Adviser, LLC	13F Company 13F	3.3%	$78,683,000 4,563,962 shares	—	31 Mar 2022
BlackRock Finance, Inc.	13F Company 13F	2.9%	$68,738,000 3,987,107 shares	—	31 Mar 2022
BVF INC/IL	13F Company 13F	2.9%	$68,556,000 3,976,543 shares	—	31 Mar 2022
Rock Springs Capital Management LP	13F Company 13F	2.8%	$66,633,000 3,865,034 shares	—	31 Mar 2022
Foresite Capital Management IV, LLC	13F Company 13F	2.1%	$49,979,000 2,899,034 shares	—	31 Mar 2022

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

112

63,269,555

Rows available

112

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

107

Q2 2022 holders

112

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 value	Q2 2022 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend